Instead Plans to Market Microbicide by 2010
Wednesday, October 18th, 2006
New Company Plans to Market Microbicide by 2010 Tommy Thompson Chairs Instead Sciences
LA JOLLA, Calif.–(BUSINESS WIRE)–Aug. 1, 2006–Local women’s health company Instead Inc. and Tommy Thompson have formed a new company called Instead Sciences, Inc. to complete the final stage of clinical trials, product development and market launch of its promising microbicide Amphora(TM) (clinically known as Acidform).
“Amphora–which already has FDA safety clearance for human use–is in the best position to be the first approved microbicide that will be available over-the-counter to protect women from HIV/AIDS,” Thompson said. “By forming a company to focus exclusively on its testing and development, we think we can be to market first.”
